In a featured interview with Pharmacy Times, LIV Process highlighted its mission to transform infection prevention by making invisible Clostridioides difficile (C. diff) contamination visible in healthcare environments. Founder and CEO Michael McIntyre discussed the urgent need for verification-based cleaning, introducing the patented LIV Process technology that enables healthcare teams to visualize viable C. diff spores on surfaces in approximately two minutes. The article emphasized how real-time visualization helps environmental services and infection prevention teams target contamination, improve cleaning effectiveness, and enhance patient safety. LIV Process continues to champion a proactive, prevention-focused approach to reducing healthcare-associated infections and saving lives.